- Previous Close
27.47 - Open
27.74 - Bid 27.63 x 27000
- Ask 27.65 x 28000
- Day's Range
27.61 - 27.75 - 52 Week Range
24.01 - 31.73 - Volume
2,648 - Avg. Volume
36,256 - Market Cap (intraday)
61.812B - Beta (5Y Monthly) 0.70
- PE Ratio (TTM)
30.03 - EPS (TTM)
0.92 - Earnings Date Nov 6, 2024
- Forward Dividend & Yield 0.51 (1.83%)
- Ex-Dividend Date Apr 19, 2024
- 1y Target Est
42.99
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.
www.siemens-healthineers.comRecent News: SMMNY
View MorePerformance Overview: SMMNY
Trailing total returns as of 9/17/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SMMNY
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SMMNY
View MoreValuation Measures
Market Cap
62.24B
Enterprise Value
60.51B
Trailing P/E
30.02
Forward P/E
18.38
PEG Ratio (5yr expected)
1.12
Price/Sales (ttm)
2.52
Price/Book (mrq)
3.06
Enterprise Value/Revenue
2.46
Enterprise Value/EBITDA
13.16
Financial Highlights
Profitability and Income Statement
Profit Margin
8.43%
Return on Assets (ttm)
3.69%
Return on Equity (ttm)
10.57%
Revenue (ttm)
22.09B
Net Income Avi to Common (ttm)
1.86B
Diluted EPS (ttm)
0.92
Balance Sheet and Cash Flow
Total Cash (mrq)
2.06B
Total Debt/Equity (mrq)
92.22%
Levered Free Cash Flow (ttm)
1.84B